| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa8bc51073f246cc40be59c3422fd26f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-18122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-50 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 |
| filingDate |
2017-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3d4989c773470f6373651b776007690
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11c230d6aaaef0ebdae002efa4662ee6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b0823701962d7a441f3ba63ed085515 |
| publicationDate |
2022-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2017263138-B2 |
| titleOfInvention |
Viral particle for RNA transfer, especially into cells involved in immune response |
| abstract |
The invention relates to a retroviral particle comprising a Gag polyprotein-derived protein, an envelope protein, optionally an integrase and at least two encapsidated non-viral RNAs, each of said encapsicated non-viral RNAs containing an RNA sequence of interest linked to an encapsidation sequence, each encapsidation sequence being recognized by a binding domain that is introduced into the Gag polyprotein-derived protein and/or into the integrase; furthermore, at least one of the sequences of interest of the encapsidated non-viral RNAs comprises a portion coding for at least one epitope and/or at least one molecular structure specifically recognizing an epitope. |
| priorityDate |
2016-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |